Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora in HLA-B27 transgenic rats

Clinical and Diagnostic Laboratory Immunology

Volumn 11, Issue 3, 2004, Pages 581-587

  Schultz, M ^a   Munro, K ^c   Tannock, G W ^c   Melchner, I ^a   Gottl C ^a   Schwietz, H ^b   Scholmerich J ^a   Rath, H C ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Nutrichem Diät Pharma GmbH   (Germany)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; HLA B27 ANTIGEN; INTERLEUKIN 1BETA; INULIN; METRONIDAZOLE; MYELOPEROXIDASE; PROBIOTIC AGENT; RNA; SYMBIOTIC INSTANT MIXTURE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIUM DETECTION; BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS; CECUM; COLITIS; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DISEASE SEVERITY; ENTERITIS; ENZYME ACTIVITY; FEEDING; GENETIC SUSCEPTIBILITY; IMMUNE RESPONSE; INFLAMMATION; INTESTINE FLORA; LACTOBACILLUS; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BACTERIA; BETA 2-MICROGLOBULIN; BIFIDOBACTERIUM; COLITIS; COLON; DNA, BACTERIAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HLA-B27 ANTIGEN; INFLAMMATORY BOWEL DISEASES; INTESTINES; INULIN; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; METRONIDAZOLE; PEROXIDASE; POLYMERASE CHAIN REACTION; PROBIOTICS; RATS; RATS, INBRED F344; SEQUENCE ANALYSIS, DNA;

EID: 2442715243     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.11.3.581-587.2004     Document Type: Article

References (44)

1. Arndt, H., K. D. Palitzsch, M. B. Grisham, and D. N. Granger. 1994. Metronidazole inhibits leukocyte-endothelial cell adhesion in rat mesenteric venules. Gastroenterology 106:1271-1276.
2. Bienenstock, J., R. E. Riley, G. S. Neigh, S. Waserman, and P. Keith. 2002. Probiotics in the management and prevention of atopy. Clin. Rev. Allergy Immunol. 22:275-285.
3. Cremonini, F., S. Di Caro, E. C. Nista, F. Bartolozzi, G. Capelli, G. Gasbarrini, and A. Gasbarrini. 2002. Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhea. Aliment. Pharmacol. Ther. 16:1461-1467.
4. Crittenden, R. G. 1999. Prebiotics, p. 141-156. In G. W. Tannock (ed.), Probiotics: a critical review. Horizon Scientific Press, Wymondham, United Kingdom.
5. Dieleman, L. A., M. S. Goerres, A. Arends, D. Sprengers, C. Torrice, F. Hoentjen, W. Grenther, and R. B. Sartor. 2003. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 52:370-376.
6. Duchmann, R., E. Schmitt, P. Knolle, K. Meyer zum Büschenfelde, and M. Neurath. 1996. Tolerance toward resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur. J. Immunol. 26:934-938.
7. Fiocchi, C. 1998. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182-205.
8. Gibson, G. R., E. R. Beatty, X. Wang, and J. H. Cummings. 1995. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenteology 108:975-982.
9. Gibson, G. R., and X. Wang. 1994. Bifidogenic properties of different types of fructo-oligosaccharides. Food. Microbiol. 11:491-498.
10. Gionchetti, P., F. Rizzello, A. Venturi, P. Brigidi, D. Matteuzzi, G. Bazzocchi, G. Poggioli, M. Miglioli, and M. Campieri. 2000. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119:305-309.
11. Grisham, M. B., J. N. Benoit, and D. N. Granger. 1990. Assessment of leukocyte involvement during ischemia and reperfusion of intestine. Methods Enzymol. 186:729-742.
12. Guarner, F., and J. R. Malagelada. 2003. Gut flora in health and disease. Lancet 361:512-519.
13. Isolauri, E. 2003. Probiotics for infectious diarrhea. Gut 52:436-437.
14. Kleesen, B., B. Sykura, H.-J. Zunft, and M. Blaut. 1997. Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. Am. J. Clin. Nutr. 65:1397-1402.
15. Knarreborg, A., M. A. Simon, R. M. Engberg, B. B. Jensen, and G. W. Tannock. 2002. Effects of dietary fat source and subtherapeutic levels of antibiotic on the bacterial community in the ileum of broiler chickens at various ages. Appl. Environ. Microbiol. 68:5981-5984.
16. Kruis, W., P. Fric, M. Stolte, and The Mutaflor Study Group. 2001. Maintenance of remission in ulcerative colitis is equally effective with Escherichia coli Nissle 1917 and with standard mesalamine. Gastroenterology 120:680.
17. Lilly, D. M., and R. H. Stilwell. 1965. Probiotics: growth promoting factors produced by microorganisms. Science 47:747-748.
18. Mack, D. R., S. Michail, S. Wei, L. McDougall, and M. A. Hollingsworth. 1999. Probiotics inhibit enteropathogenic Escherichia coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. 276:G941-G950.
19. Madsen, K. L., J. S. Doyle, L. D. Jewell, M. M. Taverini, and R. N. Fedorak. 1999. Lactobacillus species prevents colitis in interleukin-10 gene-deficient mice. Gastroenterology 116:1107-1114.
20. Madsen, K. L., A. Cornish, P. Soper, C. McKaigney, H. Jijon, C. Yachimec, J. Doyle, L. Jewell, and C. De Simone. 2001. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121:580-591.
21. Madsen, K. L., J. S. Doyle, M. M. Tavernini, L. D. Jewell, R. P. Rennie, and R. N. Fedorak. 2000. Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology 118:1094-1105.
22. Malin, M., H. Suomalainen, M. Saxelin, and E. Isolauri. 1996. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann. Nutr. Metabol. 40:137-145.
23. Obermeier, F., N. Dunger, L. Deml, H. Herfarth, and J. Schölmerich. 2002. CpG motifs of bacterial DNA exacerbate colitis of dextran sodium-treated mice. Eur. J. Immunol. 32:2084-2092.
24. Rath, H. C., M. Schultz, R. Freitag, L. A. Dieleman, F. Li, H. J. Linde, J. Schölmerich, and R. B. Sartor. 2001. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect. Immun. 69:2277-2285.
25. Rath, H. C., H. H. Herfarth, J. S. Ikeda, W. B. Grenther, T. E. Hamm, Jr., E. Balish, J. D. Taurog, R. E. Hammer, K. H. Wilson, and R. B. Sartor. 1996. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human β2-microglobulin transgenic rats. J. Clin. Investig. 98:945-953.
26. Rath, H. C., J. S. Ikeda, H. J. Linde, J. Schölmerich, K. H. Wilson, and R. B. Sartor. 1999. Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats. Gastroenterology 116:310-319.
27. Rath, H. C., K. H. Wilson, and R. B. Sartor. 1999. Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus of Escherichia coli. Infect. Immun. 67:2969-2974.
28. Rembacken, B. J., A. M. Snelling, P. M. Hawkey, D. M. Chalmers, and A. T. Axon. 1999. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354:635-639.
29. Rutgeerts, P., M. Hiele, K. Geboes, M. Peeters, F. Penninckx, R. Aerts, and R. Kerremans. 1995. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 108: 1617-1621.
30. Sartor, R. B. 1999. Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis, and experimental intestinal inflammation, p. 153-178. In J. B. Kirsner (ed.), Inflammatory bowel disease. The Williams & Wilkins Co., Baltimore, Md.
31. Sartor, R. B. 2000. New therapeutic approaches to Crohn's disease. N. Engl. J. Med. 342:1664-1666.
32. Schultz, M., H. J. Linde, N. Lehn, K. Zimmermann, J. Grossmann, W. Falk, and J. Schölmerich. 2003. Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG (L. GG) in healthy volunteers. J. Dairy. Res. 70:165-173.
33. Schultz, M., and H. C. Rath. 2002. The role of probiotics in inflammatory bowel disease, p. 175-239. In G. W. Tannock (ed.), Probiotics and prebiotics: where are we going? Horizon Scientific Press, Wymondham, United Kingdom.
34. Schultz, M., C. Veitkamp, L. A. Dieleman, R. B. Wyrick, S. L. Tonkonogy, and R. B. Sartor. 2002. Lactobacillus plantarum 299v in treatment and prevention of spontaneous colitis in IL-10-deficient mice. Inflamm. Bowel Dis. 8:71-80.
35. Seksik, P., L. Rigottier-Gois, G. Gramet, M. Sutren, P. Pochart, P. Marteau, R. Jian, and J. Doré. 2003. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 52:237-242.
36. Swidsinski, A., A. Ladhoff, A. Pernthaler, S. Swidsinski, V. Loening-Baucke, M. Ortner, J. Weber, U. Hoffmann, S. Schreiber, M. Dietel, and H. Lochs. 2002. Mucosal flora in inflammatory bowel disease. Gastroenterology 122: 44-54.
37. Tannock, G. W., K. Munro, H. J. Harmsen, G. W. Welling, J. Smart, and P. K. Gopal. 2000. Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl. Environ. Microbiol. 66:2578-2588.
38. Taurog, J. D., J. A. Richardson, J. T. Croft, W. A. Simmons, M. Zhou, J. L. Fernandes-Sueiro, E. Balish, and R. E. Hammer. 1994. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med. 180:2359-2364.
39. Vaughan, E. E., F. Schut, H. G. Heilig, E. G. Zoetendal, W. M. De Vos, and A. D. Akkermans. 2000. A molecular view of the intestinal ecosystem. Curr. Issues Intestinal Microbiol. 1:1-12.
40. Walter, J., C. Hertel, G. W. Tannock, C. M. Lis, K. Munro, and W. P. Hammes. 2001. Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl. Environ. Microbiol. 67:2578-2585.
41. Walter, J., G. W. Tannock, A. Tilsala-Timisjarvi, S. Rodtong, D. M. Loach, K. Munro, and T. Alatossava. 2000. Detection and identification of gastrointestinal Lactobacillus species by using dentauring gradient gel electrophoresis and species-specific PCR primers. Appl. Environ. Microbiol. 66: 297-303.
42. Welters, C. F., E. Heinemann, F. B. Thunnissen, A. E. van den Bogaard, P. B. Soeters, and C. G. Baeten. 2002. Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis. Dis. Colon Rectum 45:621-627.
43. Yacyshyn, B., G. Armstrong, G. W. Tannock, and M. B. Bowen-Yacyshyn. 2003. Carboxy-Methycellulose decreasescolonic inflammation and changes bacterial flora in the HLA-B27 transgenic rat. Gastroenterology 118:T1152.
44. Zoetendal, E. G., A. D. Akkermans, and W. M. De Vos. 1998. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl. Environ. Microbiol. 64:3854-3859.